APA
Breitz H. B., Weiden P. L., Vanderheyden J. L., Appelbaum J. W., Bjorn M. J., Fer M. F., Wolf S. B., Ratliff B. A., Seiler C. A. & Foisie D. C. (19920706). Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Chicago
Breitz H B, Weiden P L, Vanderheyden J L, Appelbaum J W, Bjorn M J, Fer M F, Wolf S B, Ratliff B A, Seiler C A and Foisie D C. 19920706. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
Harvard
Breitz H. B., Weiden P. L., Vanderheyden J. L., Appelbaum J. W., Bjorn M. J., Fer M. F., Wolf S. B., Ratliff B. A., Seiler C. A. and Foisie D. C. (19920706). Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
MLA
Breitz H B, Weiden P L, Vanderheyden J L, Appelbaum J W, Bjorn M J, Fer M F, Wolf S B, Ratliff B A, Seiler C A and Foisie D C. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 19920706.